Condition: Ulcerative Colitis (UC) · Crohns Disease · Sponsor: Asian Institute of Gastroenterology, India
Healthcare contributes approximately 4.4% of global GHG emissions, with diagnostic imaging and endoscopic services being substantial contributors. Colonoscopy and cross-sectional imaging modalities, though indispensable, are associated with high carbon emissions due to electricity use, waste, sterilisation, and transportation. IBUS, a non-invasive, real-time diagnostic modality, is increasingly validated for disease activity assessment in both UC and CD.
This description comes directly from the study's public registry record.
Dr.Hardik Rughwani · 9426928600 · dr.hardikr@aighospitals.com
Always discuss trial participation with your own doctor first.
| AIG Hospitals | Hyderabad, Telangana, India | Recruiting |
| AIG Hospitals | Hyderabad, Telangana, India | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07431983